art-blur-calculator-270549-2.jpg

Why Invest?

 
 

Why Invest In Biotech?

The burgeoning field of biotechnology creates and enhances products and services for many industries; among them, agriculture, biofuels, and, most notably, vaccines and medicine.  Although the pharmaceutical industry leads handily in healthcare revenue, biotech is quickly closing in with a 2020 forecast of over $100 billion in the U.S. alone. But biotech beats pharma in speed of growth, with annual growth rate estimated at 10% compared to pharma’s 4%.   

Radiance Bio offers an excellent opportunity to capitalize on biotech’s steady expansion while advancing vital life-sciences research and lab work. We focus solely on assay development and sample testing. We do not manage the client’s product manufacturing, licensing, or distribution, which are restricted by FDA oversight.  To learn more about investing in Radiance, contact us at (847) 578-8485 or email siva@radiancebiosciences.com. 


Investment in Biotech Growth

The rapidly growing field of biotechnology creates and enhances products and services for far-reaching industries such as agriculture, biofuels, and most notably vaccines and medicine. 

While at present the pharmaceutical industry remains ahead in healthcare revenue, biotech is quickly closing in, with a forecasted market estimate of more than $100 billion by 2020 in the U.S. alone. Globally, analysts predict a 10% annual growth rate as compared with 4% for pharmaceuticals. 

Radiance Biosciences & Consultancy, LLC offers an excellent opportunity to capitalize on this steady expansion while furthering socially vital life sciences research and lab work. We focus solely on assay development and sample testing; we do not manage the client’s product manufacturing, licensing or distribution, which are restricted by FDA oversight. 

For more information about investment opportunity with RBC, please contact us at (847) 578-8485 or siva@radiancebiosciences.com.